-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AnRSqNRzZunJT39YHuMP7wOLbtPVfxdXYqQAfBRM2eVm+EwmnWiMFzAkEGOXC/PO FFBroZI1ZLiC75PkWhb+7g== 0000950133-06-004856.txt : 20061109 0000950133-06-004856.hdr.sgml : 20061109 20061109165434 ACCESSION NUMBER: 0000950133-06-004856 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060930 FILED AS OF DATE: 20061109 DATE AS OF CHANGE: 20061109 EFFECTIVENESS DATE: 20061109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06964 FILM NUMBER: 061203106 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 13F-HR 1 w26916ae13fvhr.txt 13F-HR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2006 --------------------------- Check here if Amendment [ ]; Amendment Number: -------- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG ------------------------------------------ Address: Vordergasse 3 ------------------------------------------ Schaffhausen Switzerland CH-8200 ------------------------------------------ ------------------------------------------ Form 13F File Number: 28-6964 ------------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Adrian Bruengger -------------------------------------------- Title: SIGNING AUTHORITY -------------------------------------------- Phone: 41 (01) 267 67 00 -------------------------------------------- Signature, Place, and Date of Signing: /s/ Adrian Bruengger ---------------------------------------- Schaffhausen, Switzerland, November 7, 2006 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 3 ----------------------- Form 13F Information Table Entry Total: 19 ----------------------- Form 13F Information Table Value Total: $1,413,328 ----------------------- (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 28-11193 Biotech Focus N.V. ----- ------------------ ------------------------ 2 28-11191 Biotech Invest N.V. ----- ------------------ ------------------------ 3 28-11189 Biotech Target N.V. ----- ------------------ ------------------------ BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - ------------------------------------------------------------------------------------------------------------------------------------ NAME OF TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY ISSUER CLASS CUSIP [x$1000] PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ------------------------------------------------------------------------------------------------------------------------------------ Adolor Corp. COM 00724X102 5,201 375,000 SH DEFINED 3 375,000 NONE NONE Affymetrix COM 00826T108 43,120 2,000,000 SH DEFINED 1 2,000,000 NONE NONE Amgen COM 031162100 89,413 1,250,000 SH DEFINED 1 1,250,000 NONE NONE Anadys Pharmaceuticals COM 03252Q408 5,800 2,000,000 SH DEFINED 3 2,000,000 NONE NONE Arena Pharmaceuticals COM 040047102 11,980 1,000,000 SH DEFINED 3 1,000,000 NONE NONE Biogen Idec COM 09062X103 213,213 4,772,000 SH DEFINED 1 4,772,000 NONE NONE Celgene COM 151020104 241,480 5,576,900 SH DEFINED 2 5,576,900 NONE NONE Cephalon COM 156708109 19,081 309,000 SH DEFINED 1 309,000 NONE NONE Elan Corp COM 284131208 44,460 2,850,000 SH DEFINED 2 2,850,000 NONE NONE Genentech COM 368710406 169,535 2,050,000 SH DEFINED 1 2,050,000 NONE NONE Genzyme COM 372917104 77,765 1,152,584 SH DEFINED 1 1,152,584 NONE NONE Gilead COM 375558103 228,737 3,326,109 SH DEFINED 1 3,326,109 NONE NONE Incyte COM 45337C102 12,690 3,000,000 SH DEFINED 3 3,000,000 NONE NONE Keryx Biopharmaceuticals COM 492515101 11,112 939,311 SH DEFINED 3 939,311 NONE NONE Onyx Pharmaceuticals COM 683399109 34,580 2,000,000 SH DEFINED 2 2,000,000 NONE NONE Rigel Pharmaceuticals COM 766559603 10,270 1,000,000 SH DEFINED 3 1,000,000 NONE NONE The Medicines Company COM 584688105 57,670 2,556,277 SH DEFINED 3 2,556,277 NONE NONE Vertex Pharmaceuticals COM 92532F100 100,950 3,000,000 SH DEFINED 3 3,000,000 NONE NONE Zymogenetics COM 98985T109 36,271 2,150,053 SH DEFINED 3 2,150,053 NONE NONE
-----END PRIVACY-ENHANCED MESSAGE-----